San Francisco-based Olema and Aurigene Discovery Technologies, a wholly-owned unit of Dr. Reddy's Laboratories of Hyderabad, India have inked an exclusive global license agreement to research, develop, and commercialize novel small molecule inhibitors of an undisclosed oncology target. Under the terms of the agreement, Olema will make an upfront licensing...